Waddell & Associates, LLC Pfizer Inc Transaction History

Waddell & Associates, LLC

$755 Million
Q2 2024

A detailed history of Waddell & Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Waddell & Associates, LLC holds 24,590 shares of PFE stock, worth $675,241. This represents 0.09% of its overall portfolio holdings.

Number of Shares

24,590

Previous 13,043 88.53%

Holding current value

$675,241

Previous $361,000 90.58%

% of portfolio

0.09%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $291,677 - $341,791	11,547 Added 88.53%	24,590 $688,000
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $198,084 - $227,464	-7,651 Reduced 36.97%	13,043 $361,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $359,862 - $467,421	-13,772 Reduced 39.96%	20,694 $595,000
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $2,727 - $3,188	85 Added 0.25%	34,466 $1.14 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $92,720 - $107,274	-2,567 Reduced 6.95%	34,381 $1.26 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $77,361 - $100,713	1,964 Added 5.61%	36,948 $1.51 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $13,735 - $17,930	329 Added 0.95%	34,984 $1.79 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $1,925 - $2,350	44 Added 0.13%	34,655 $1.52 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $977 - $1,158	-21 Reduced 0.06%	34,611 $1.82 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $87,977 - $109,014	1,923 Added 5.88%	34,632 $1.79 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $149,165 - $221,112	3,610 Added 12.41%	32,709 $1.93 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $25,591 - $32,873	-652 Reduced 2.19%	29,099 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $1.07 Million - $1.21 Million	29,751 New	29,751 $1.17 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waddell & Associates, LLC with notifications on news.

Account

Waddell & Associates, LLC Pfizer Inc Transaction History